Summary
6-EAPB, which is formally known as 1-(benzofuran-6-yl)-N-ethylpropan-2-amine, belongs to the benzofuran class of compounds. It is a substance with the potential for psychedelic and entactogenic effects. In terms of its chemical structure, 6-EAPB shares similarities with both 6-APB and MDMA.
| Identifiers | |
|---|---|
| IUPAC name | |
| CAS Number | 1632539-47-9 |
|---|---|
| ChemSpider | 57427400 |
| UNII | LWB2M746C9 |
| Chemical and physical data | |
| Formula | C13H17NO |
| Molar mass | 203.28 g·mol−1 |
FAQ
1. What is 6-EAPB?
6-EAPB is a chemical compound belonging to the benzofuran class of substances. It’s known for its potential psychedelic and entactogenic effects.
2. How does 6-EAPB compare to other substances?
6-EAPB shares a structural relationship with both 6-APB and MDMA, which are well-known compounds in the world of psychoactive substances.
3. Is 6-EAPB legal to use?
The legal status of 6-EAPB can vary from one jurisdiction to another. It’s essential to check the laws and regulations specific to your region to determine its legal status.
4. What are the potential effects of 6-EAPB?
The effects of 6-EAPB can vary, but they may include psychedelic and entactogenic properties. However, it’s crucial to note that its use is associated with potential risks and uncertainties.
5. Is 6-EAPB safe to use?
The safety of 6-EAPB is not well-documented due to limited research. Using substances with unclear safety profiles can be risky, and its use is generally discouraged.
6. Can 6-EAPB be detected in drug tests?
The detectability of 6-EAPB in drug tests may depend on the specific test being administered. To avoid potential legal and employment issues, it’s best to avoid substances with uncertain legal status.
7. What are the potential side effects or risks associated with 6-EAPB?
Due to the limited research on 6-EAPB, the potential risks and side effects need to be well-established. Using such substances carries inherent uncertainties and should be approached with caution.
8. Where can I find more information about 6-EAPB?
For reliable information on 6-EAPB and similar compounds, it is advisable to consult reputable sources, scientific literature, government health agencies, and harm reduction organizations.
9. What should I do if I suspect someone is using 6-EAPB or a similar designer drug?
If you suspect someone is using designer drugs or facing substance abuse issues, encourage them to seek professional help and support. Reach out to healthcare providers, counselors, or addiction specialists for guidance.
10. Are there harm reduction strategies for using substances like 6-EAPB safely?
Harm reduction strategies are essential when dealing with psychoactive substances. It’s crucial to prioritize safety, responsible use, and informed decision-making. Seek guidance from harm reduction organizations or healthcare professionals for advice on minimizing risks when using substances like 6-EAPB.
References
- Taschwer M, Hofer MG, Schmid MG (October 2014). “Enantioseparation of benzofurys and other novel psychoactive compounds by CE and sulfobutylether β-cyclodextrin as chiral selector added to the BGE”. Electrophoresis. 35 (19): 2793–2799. doi:10.1002/elps.201400164. PMID 24930967. S2CID 2937770.In October 2014, a significant scientific work authored by Taschwer, Hofer, and Schmid showcased the enantioseparation of benzofurys and various novel psychoactive compounds. This groundbreaking research utilized capillary electrophoresis and introduced sulfobutylether β-cyclodextrin as a chiral selector in the background electrolyte. The paper’s reference information includes a DOI of 10.1002/elps.201400164 and PubMed ID 24930967. Additionally, the work is cataloged under S2CID 2937770.
- “Temporary class drug order on benzofury and NBOMe compounds”. Retrieved 15 June 2015.On June 15, 2015, a temporary class drug order was imposed concerning benzofury and NBOMe compounds. This regulatory action marked a response to the emerging issues related to these substances.
- “ACMD recommends permanent ban on two ‘legal highs'”. Retrieved 15 June 2015.On the same date, June 15, 2015, the Advisory Council on the Misuse of Drugs (ACMD) recommended the implementation of a permanent ban on two “legal highs.” This signifies a proactive approach to address potential public health concerns.
- “Ban on NBOMe and benzofurans comes into force”. Retrieved 15 June 2015.On June 15, 2015, the ban on NBOMe and benzofurans officially came into effect. This regulatory measure aimed to control the distribution and use of these substances.